product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
IRAK4 Antibody
catalog :
4363P
quantity :
40 ul
price :
123 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human, mouse, rat
application :
western blot, immunoprecipitation
citations: 2
Published Application/Species/DilutionReference
  • western blot; human; 1:200; fig st1
Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
Davidson D, Currie A, Bowdish D, Brown K, Rosenberger C, Ma R, et al. IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells. J Immunol. 2006;177:8202-11 pubmed
product information
SKU :
4363P
Product-Name :
IRAK4 Antibody
Size :
40 ul
Price-(USD) :
123 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Immunoprecipitation
Product-Category :
Immunology and Inflammation
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
55
Host :
Rabbit
Target :
IRAK4
Primary-Protein :
IRAK4
Alt-Names :
IPD1,IRAK-4,IRAK4,Interleukin-1 receptor-associated kinase 4,NY-REN-64,Q8TDF7,REN64,Renal carcinoma antigen NY-REN-64
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.